Menu Search
Equities

Sartorius Stedim Biotech SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert
DIMN:MEX

Sartorius Stedim Biotech SA

Actions
  • Price (MXN)4,194.65
  • Today's Change762.06 / 22.20%
  • Shares traded--
  • 1 Year change--
  • Beta1.3325
Data delayed at least 20 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
OPERATIONS
Net income2194011,130
Depreciation/depletion302238182
Non-Cash items15450(133)
Cash taxes paid, supplemental134136221
Cash interest paid, supplemental17711710
Changes in working capital14158(567)
Total cash from operations815746612
INVESTING
Capital expenditures(340)(474)(431)
Other investing and cash flow items, total(0.2)(2249)(527)
Total cash from investing(340)(2723)(958)
FINANCING
Financing cash flow items(178)(205)(52)
Total cash dividends paid(67)(133)(116)
Issuance (retirement) of stock, net1,1921.30(3.2)
Issuance (retirement) of debt, net(862)2,323392
Total cash from financing851,986221
NET CHANGE IN CASH
Foreign exchange effects2.30(0.3)8.00
Net change in cash5629.50(117)
Net cash-begin balance/reserved for future use117107224
Net cash-end balance/reserved for future use679117107
SUPPLEMENTAL INCOME
Depreciation, supplemental302238182
Cash interest paid, supplemental17711710
Cash taxes paid, supplemental134136221
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.